Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05958381 · ClinicalTrials.gov registry record · NA

Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation

A NA study of Multiple Sclerosis (Relapsing Remitting), sponsored by The University of Texas at Dallas.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05958381 is a NA study of Multiple Sclerosis (Relapsing Remitting) that is actively recruiting participants, run by The University of Texas at Dallas. The registered enrollment target is 100 participants, below the 559-participant average among 29 other Multiple Sclerosis (Relapsing Remitting) trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05958381, a NA study of Multiple Sclerosis (Relapsing Remitting), is actively recruiting participants, sponsored by The University of Texas at Dallas.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., presupplementary motor area) thought to aid in memory will improve verbal retrieval in multiple sclerosis patients. The primary outcome measures are neuropsychological assessments of verbal retrieval, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures. Additionally, the study will examine the degree to which baseline assessments of cognition and concussion history predict responses to treatment over time, both on assessments administered within the intervention period and at follow-up.

Conditions Studied

Multiple Sclerosis (Relapsing Remitting)

Interventions

  • DEVICE Sham transcranial direct current stimulation
  • DEVICE Transcranial Direct Current Stimulation

Study Locations (1)

Texas

  • The University of Texas at Dallas - Richardson

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-10-18
Est. Completion 2027-06-30
Phase NA

Sponsor

The University of Texas at Dallas

50 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05958381

The ClinicalTrials.gov registry entry for NCT05958381 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 559-participant average among 29 other Multiple Sclerosis (Relapsing Remitting) trials with a reported enrollment target (82% lower). The listed sponsor is The University of Texas at Dallas, which has 50 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis (Relapsing Remitting) appearing as the primary indexed condition, and to 2 interventions - of which Sham transcranial direct current stimulation is the first listed.

NCT05958381 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05958381 about?

NCT05958381 is a clinical study titled "Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation". The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., presupplementary motor area) thought to aid in memory will improve verbal retrieval in multiple sclerosis patients. The primary outcome m...

What is the current status of trial NCT05958381?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-10-18. Estimated completion is 2027-06-30.

What conditions does trial NCT05958381 study?

This clinical trial studies the following conditions: Multiple Sclerosis (Relapsing Remitting).

What interventions are being tested in trial NCT05958381?

The interventions under investigation include: Sham transcranial direct current stimulation (DEVICE), Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05958381?

This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05958381 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis (Relapsing Remitting)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis (Relapsing Remitting)

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.